Raymond W. Cohen

CIK: 0001258288

Transaction Breakdown

Open Market Buys (P)2 (20.0%)

High conviction signal

Open Market Sales (S)1 (10.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

KMTS

KESTRA MEDICAL TECHNOLOGIES, LTD.

Director

RXST

RxSight, Inc.

Director

NSPR

InspireMD, Inc.

Director

AXNX

Axonics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Sep 30, 2026
Sale(S)
Direct
3.3K shares at avg. $29.28$98K
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Sep 9, 2026
Award(A)
Direct
7.2K shares-
RXST
RxSight, Inc.
Jun 17, 2026
Award(A)
Direct
30.9K shares-
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Mar 26, 2026
Purchase(P)
Direct
10K shares at avg. $19.98$200K
NSPR
InspireMD, Inc.
Jan 14, 2026
Award(A)
Direct
44K shares-
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Sep 4, 2025
Award(A)
Direct
10.9K shares-
RXST
RxSight, Inc.
Jul 31, 2025
Award(A)
Direct
35.7K shares-
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Jul 24, 2025
Award(A)
Direct
13K shares-
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Mar 7, 2025
Purchase(P)
Direct
17K shares at avg. $17.00$289K
AXNX
Axonics, Inc.
Nov 15, 2024
Disposition(D)
Direct
292.7K shares at avg. $71.00$20.8M

		Type	Shares	Price		Ownership
Sep 30, 2026	KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.	Sale(S)	3,330	$29.28	$97,504	Direct
Sep 9, 2026	KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.	Award(A)	7,217	-	$0	Direct
Jun 17, 2026	RXST RxSight, Inc.	Award(A)	30,864	-	$0	Direct
Mar 26, 2026	KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.	Purchase(P)	10,000	$19.98	$199,800	Direct
Jan 14, 2026	NSPR InspireMD, Inc.	Award(A)	44,030	-	$0	Direct
Sep 4, 2025	KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.	Award(A)	10,909	-	-	Direct
Jul 31, 2025	RXST RxSight, Inc.	Award(A)	35,668	-	-	Direct
Jul 24, 2025	KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.	Award(A)	12,994	-	-	Direct
Mar 7, 2025	KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.	Purchase(P)	17,000	$17.00	$289,000	Direct
Nov 15, 2024	AXNX Axonics, Inc.	Disposition(D)	292,731	$71.00	$20,783,901	Direct

1-10 of 10 transactions

About COHEN RAYMOND W

COHEN RAYMOND W (SEC CIK 0001258288) files insider reports with the SEC as Director of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS), Director of RxSight, Inc. (RXST) and Director of InspireMD, Inc. (NSPR). Signal8 also holds filings tied to 1 other company.

Signal8 holds 12 ownership filings by COHEN RAYMOND W (3 Form 3, 9 Form 4), filed between Nov 15, 2024 and Oct 1, 2026. Those filings report 10 transactions, from Nov 15, 2024 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on COHEN RAYMOND W's filings is in KIRKLAND, WA.

Recent filings by COHEN RAYMOND W

Sep 30, 2026: Open-market sale of KMTS shares (Form 4, code S).
Sep 9, 2026: Grant or award of KMTS shares (Form 4, code A).
Jun 17, 2026: Grant or award of RXST shares (Form 4, code A).
Mar 26, 2026: Open-market purchase of KMTS shares (Form 4, code P).
Jan 14, 2026: Grant or award of NSPR shares (Form 4, code A).

Other insiders filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

How to read Form 4 transaction codes